654
Views
9
CrossRef citations to date
0
Altmetric
Research Article

The effect of angiotensin-converting enzyme inhibition by captopril on respiratory mechanics in healthy rats

, &
Pages 854-860 | Received 27 Jul 2011, Accepted 07 Sep 2011, Published online: 16 May 2012

Abstract

Context: Angiotensin stimulates smooth-muscle contraction. Accordingly, angiotensin-converting enzyme (ACE) inhibition is expected to decrease airway resistance.

Objectives: To measure the effects of ACE inhibition on respiratory mechanics in healthy mammals.

Materials and methods: We measured respiratory mechanics before and after i.p. ACE inhibitor captopril (100 mg/kg) in normal anaesthetised rats. The end-inflation occlusion method allowed the measurements of respiratory system elastance and ohmic and viscoelastic pressure dissipations. Respiratory system hysteresis and the elastic and resistive work of breathing were calculated.

Results: Captopril induced a reduction of the ohmic and the total respiratory system resistances, while respiratory system hysteresis and elastance did not change. Accordingly, a reduction of the resistive and of the total work of breathing was observed.

Conclusions: The captopril-induced reduction of airway resistance indicates that angiotensin modulates bronchomotor tone in basal conditions. ACE inhibition may positively affect respiratory system mechanics and work of breathing.

Introduction

The angiotensin plasma concentration is increased and potentiates bronchoconstriction in asthmatic subjectsCitation1,Citation2. Angiotensin has also been shown to cause bronchoconstriction in guinea pigsCitation3 and ratsCitation4,Citation5, and bronchial hyperresponsiveness to metacholine in human asthmatic subjectsCitation2,Citation6 and guinea pigsCitation3.

Furthermore, the inhibition of angiotensin receptors of type 1, but not of type 2, has been shown to prevent in a dose-related manner the metacholine-induced bronchoconstriction in normalCitation3 and inhalating antigen guinea pigsCitation7. Angiotensin-elicited bronchoconstriction was also shown to be inhibited by type 1 angiotensin receptor antagonismCitation4 and/or angiotensin-converting enzyme (ACE) inhibition in ratsCitation5.

Some data suggest that angiotensin may exert its biological effects in normal healthy subjects in basal conditions also. For example, it is well-known that low dosages of the ACE inhibitor captopril show their hypotensive effects in normal subjectsCitation8.This suggests that ACE inhibition might influence bronchial smooth muscle tone of normal subjects also. Moreover, angiotensin has been shown to cause contraction of bronchial rings taken from normal ratsCitation4,Citation5, and bronchoconstriction in healthy guinea pigsCitation3.

However, Jamison and GloverCitation9 observed no effect of ACE inhibition either on basal airway mechanics or on hypocapnic hyperventilation-induced bronchoconstriction in normal subjects. Moreover, ACE inhibition has been demonstrated to leave unaltered baseline lung function in normal subjectsCitation10, and basal airway resistance and bradychinine-induced bronchoconstriction in guinea pigsCitation11. Type 1 angiotensin receptor antagonism did not alter airway resistance in normal guinea pigsCitation7. In addition, greater decreases of pulmonary conductance caused by substance P were observed in captopril-treated guinea pigs than in control animals, suggesting that angiotensin may even exert a bronchodilator effectCitation12.

Thus, the reported effects of angiotensin and/or of ACE or angiotensin receptors inhibition on the airway resistance of normal healthy mammals are conflicting.

No data are available describing the possible effects of ACE inhibition, hence indirectly of basal angiotensin plasma concentration, on other respiratory system mechanics parameters such as on viscoelastic resistance due to stress relaxation, and on elastance. These may be easily measured, together with the ohmic airway resistance, by the end-inflation occlusion methodCitation13–16, which has never been applied to study the angiotensin’s effects on respiratory mechanics.

Stress relaxation is a complex phenomenon, exhibited by most tissues, including the lungs, whose molecular basis are essentially unclear. Due to their viscoelastic properties, the tissues do not maintain constant stress under constant deformation, but slowly relax. The viscoelastic pressure component of the inspiratory work of breathing contributes significantly to the overall breathing pressure dissipationCitation13–16. Hence, the study of the factors possibly affecting stress relaxation has practical connotations, because any effect reducing the viscoelastic component of the inspiratory work of breathing may suggest therapeutical implications. According to Potter et al.Citation17 and Martin et al.Citation18, the contractile activity of the peripheral cellular elements in the lungs may be changed by smooth muscle activity-influencing agents such as nitric oxide. Hence, a possible effect of angiotensin and/or ACE inhibition on respiratory system stress relaxation and elastance may not be excluded. These aspects have never been investigated before.

Although some biochemical interactions between angiotensin and alveolar surfactant dipalmitoylphosphatidylcholine have been describedCitation19, the possible effects of angiotensin and/or ACE inhibition on respiratory system hysteresis have never been measured.

Thus, in the present report in vivo measurements of healthy normal rats respiratory system mechanics are described, taken before and after ACE inhibition by intraperitoneal captopril. The aim of the experiments is to measure by the end-inflation occlusion method the effects of basal angiotensin plasma concentration on the ohmic and viscous-elastic respiratory system resistances, and on respiratory system elastance, in anaesthetised healthy mammals in basal conditions. The possible effects on respiratory system hysteresis have been also for the first time investigated. In addition, the effects of ACE inhibition on the total inspiratory work of breathing and on its elastic and resistive components were studied, which has never been done before.

Methods

The experiments were carried out on 9 Wistar albino rats of both sexes (mean weight 307 ± 31 g, 4 males and 5 females).

Animals were housed and treated in accordance with the Italian law on animal experimentation (L. 116/92) and with the European Council (EC) provision 86/609/EEC. The experimental protocol received the approbation of the local ethical committee (CEASA, University of Padova, ref. no. 24bis/2011).

Rats were anesthetized with 50 mg/100 g i.p. chloralose and laid on a heated operating table. After a tracheostomy, a small polyethylene cannula (2 mm i.d, 5 cm long) was inserted through an incision in the second tracheal ring and firmly secured in place.

Positive pressure ventilation with a 10 mL/kg tidal volume and a 60/min breathing frequency (PEEP 3 cmH2O) (Rodent Ventilator 7025, Basile, Italy) was begun, and constantly maintained throughout the experiment.

The level of anesthesia was tested by checking the suppression of the corneal reflex.

Limb ECG probes were placed and the rats were paralyzed (cis-atracurium 1 mg/100 g i.p.).

Additional doses of cis-atracurium, a drug that does not appear to substantially alter heart rateCitation20, were administered as needed whenever spontaneous breathing appeared.

Positive pressure ventilation was maintained for 10 min and respiratory mechanics were then measured using the end-inflation occlusion methodCitation13–16.

The ventilator was disconnected, PEEP was discontinued, and the tracheal cannula was connected to a constant flow pump (SP 2000 Series Syringe Pump sp210iw, World Precision Instruments, USA) set to deliver a tidal volume (VT) of 3 mL with a square wave flow (F) of 4 mL/s. The time for the rise and the fall of the flow was approximately 30 ms. The pump setting was carefully checked by directly taking measurements before beginning the experiments.

The lateral tracheal pressure proximal to the tracheal cannula was monitored (142 pc 01d, Honeywell, USA) and continuously recorded (1326 Econo Recorder, Biorad, Italy). Because abrupt changes in diameters were not present in the circuit, errors in flow resistance measurements, such as those reported by Chang and MortolaCitation21, were avoided. The frequency response of the transducer and the pressure measuring system was tested by sinusoidal forcing and found to be flat up to 20 Hz. In accordance with the literatureCitation15,Citation22, this frequency response was adequate to avoid mechanical artifacts in the pressure signal records.

The end-inflation occlusion method was utilised to determine the parameters of respiratory mechanics: the static elastic pressure of the respiratory system (Pel,rs), the total resistive pressure drop (Pmax,rs) and the sudden Newtonian resistive pressure drop at flow interruption (Pmin,rs) were measured on adequately magnified tracings (). Pmax,rs was calculated as the difference between the maximum value of pressure at end-inflation (Pdyn,max) and Pel,rs. Pmin,rs was calculated as the difference between Pdyn,max and P1, the pressure value immediately after flow interruption ().

Figure 1.  Representative tracings of lateral tracheal pressure at flow interruption. Panels A and B show tracings recorded before and 20 min after i.p. 100 mg/kg captopril administration, respectively, in the same rat. The relevant pressures used for the calculations of respiratory system mechanics are indicated: maximal pressure at end-inflation (Pdyn,max), pressure immediatly after flow interruption (P1), static elastic pressure of the respiratory system (Pel,rs), pressure drop due to the ohmic respiratory system resistance (Pmin,rs) and total pressure drop including the effects of stress relaxation (Pmax,rs).

Figure 1.  Representative tracings of lateral tracheal pressure at flow interruption. Panels A and B show tracings recorded before and 20 min after i.p. 100 mg/kg captopril administration, respectively, in the same rat. The relevant pressures used for the calculations of respiratory system mechanics are indicated: maximal pressure at end-inflation (Pdyn,max), pressure immediatly after flow interruption (P1), static elastic pressure of the respiratory system (Pel,rs), pressure drop due to the ohmic respiratory system resistance (Pmin,rs) and total pressure drop including the effects of stress relaxation (Pmax,rs).

To avoid a viscous pressure component in Pmin,rs, P1 values were identified by extrapolating the pressure tracings to the time the flow stoppedCitation23. Thus, Pmin,rs represents the nearly instantaneous, Newtonian resistive pressure drop that theoretically occurs at infinite breathing frequencyCitation23. Pmin,rs does not include the viscoelastic pressure drop that results from stress relaxation which is, instead, included in the Pmax,rs value.

The mean pressure data obtained from the three to five inflations for each rat were used to calculate the respiratory system static elastance (Est,rs = Pel,rs/VT) and the total resistance of the respiratory system (Rmax,rs = Pmax,rs/F). The latter includes the ohmic inspiratory resistance to airflow offered by the airways and the resistance caused to the movement of respiratory system tissues (Rmin,rs = Pmin,rs/F), and the viscoelastic pressure drop resulting from the effect of stress relaxation. This last component of Rmax,rs was isolated and quantified as “viscous” resistance (Rvisc,rs = Rmax,rs – Rmin,rs).

The equipment resistance, including the tracheal cannula and the standard three-way stopcock, was measured separately at a flow rate of 4 mL/s and amounted to 0.0575 cmH2O/(mL/s) (Req). All inflations were performed at a fixed flow rate of 4 mL/s, and Req was subtracted from the results, which thus represent intrinsic values.

The work of breathing (WOBrs) values were calculated as previously describedCitation16,Citation24,Citation25, and outlined in . Static pressure-volume relationships were assumed to be linear up to an inflation volume of 3 mL. This measurement is in agreement with published data showing essentially linear pressure-volume relationships for the rat respiratory system within this volume rangeCitation16,Citation24,Citation26,Citation31. The validity of this assumption has also been confirmed experimentally by the essentially linear pressure-volume relationships observed during static inflations performed for Hy,rs measurements up to a total inflation volume of 5 mL (see below). The total work of breathing (WOBtot,rs) was calculated by measuring the surface areas delimited by the total pressure (Pdyn) tracings from which the resistive pressure due to the tracheal cannula and three-way stopcock was subtracted. The elastic work of breathing (WOBel,rs) was obtained on the same diagram as the areas encompassing the static pressure/volume lines. The resistive work of breathing (WOBres,rs) was obtained by subtraction: WOBres,rs = WOBtot,rs – WOBel,rs. WOBres,rs was also partitioned into the resistive work required to overcome ohmic airway resistance and respiratory system tissue movements (WOBohm,rs) and the resistive work required to overcome the effects of stress relaxation (WOBvisc,rs). WOBohm,rs was calculated as the area comprised between the Pdyn and P1 lines, where P1 is the pressure value immediately after flow interruption (see ). WOBvisc,rs was calculated by subtraction as WOBvisc,rs = WOBres,rs – WOBohm,rs. Calculations were made for each rat and the mean values were statistically compared.

Figure 2.  Schematic drawing of the pressure/volume relationship during constant flow inflation and flow interruption. Area 1 represents the elastic work of breathing (WOBel,rs), whereas areas 2 + 3 represent the total resistive work of breathing (WOBres,rs).WOBel,rs + WOBres,rs = total inspiratory work of breathing (WOBtot,rs). Area 3 represents the ohmic work of breathing (WOBohm,rs), dissipated to overcome ohmic airways resistance plus the viscous resistance to the movement opposed by the lungs and chest wall tissues. WOBres,rs−WOBohm,rs = WOBvisc,rs, the mechanical work done to overcome the resistive effects of stress relaxation.

Figure 2.  Schematic drawing of the pressure/volume relationship during constant flow inflation and flow interruption. Area 1 represents the elastic work of breathing (WOBel,rs), whereas areas 2 + 3 represent the total resistive work of breathing (WOBres,rs).WOBel,rs + WOBres,rs = total inspiratory work of breathing (WOBtot,rs). Area 3 represents the ohmic work of breathing (WOBohm,rs), dissipated to overcome ohmic airways resistance plus the viscous resistance to the movement opposed by the lungs and chest wall tissues. WOBres,rs−WOBohm,rs = WOBvisc,rs, the mechanical work done to overcome the resistive effects of stress relaxation.

After respiratory mechanics were measured, which took approximately 1 min, mechanical ventilation was restored and maintained for 5 min. To obtain a constant volume history for the measurement of respiratory system hysteresis, the respiratory system was inflated with a 10-mL syringe to a static elastic pressure of 20–25 cmH2O three times. After that, the respiratory system was inflated, and subsequently deflated, 5 times in 1-mL steps using a precision glass syringe starting from the functional residual capacity (FRC). Each volume was maintained at each step for approximately 5–6 s. The relevant static elastic pressures were measured, and the static inflation-deflation volume–pressure curves were determined. The hysteresis areas (Hy,rs) were quantified using electronic digital integration and expressed as cmH2O·mL.

The ventilator was disconnected and PEEP was not present during the constant flow inflations to measure respiratory mechanics parameters nor during the 1-mL inflations and deflations to measure Hy,rs.

The measurements and calculations described above were repeated for each rat 10 and 20 min following 100 mg/kg captopril dissolved in 1-mL saline i.p. administration.

Data in the literature and obtained in our laboratory indicate that mechanical ventilation parameters here adopted are not injurious to the rat respiratory system (ref. 24 and related references). This excludes the possibility that any observed alterations were due to a time-related effect.

The temporal sequence of the experimental procedure is summarised in .

Figure 3.  Temporal sequence during experimental procedure: •: Start of mechanical ventilation, RM: respiratory mechanics measurements, *: electrocardiogram, Hy: Hy,rs measurement. ↑: i.p. injection.

Figure 3.  Temporal sequence during experimental procedure: •: Start of mechanical ventilation, RM: respiratory mechanics measurements, *: electrocardiogram, Hy: Hy,rs measurement. ↑: i.p. injection.

Each rat being the control of itself, statistical analysis was performed by using the Student’s t test for paired data.

Results

We found that ACE inhibition by captopril caused a significant decrement of Rmin,rs both at 10 and 20 min after i.p. administration (), and similar results were observed for Rmax,rs also (). Although a trend indicating a time-related reduction of Rvisc,rs was observed after captopril administration (), the changes did not achieve statistical significance (although because of the result pertaining to one rat only of nine). No significant alterations in Est,rs nor in Hy,rs mean values were observed after captopril ().

Figure 4.  Mean values (n = 9) of Rmax,rs (A), Rmin,rs (B) and Rvisc,rs (C) before and after 10 and 20 min captopril administration (time of injection indicated by the vertical arrow). *p < 0.05, **p < 0.01 and ^p = 0.07 with respect to values before captopril. Vertical bars represent one SE.

Figure 4.  Mean values (n = 9) of Rmax,rs (A), Rmin,rs (B) and Rvisc,rs (C) before and after 10 and 20 min captopril administration (time of injection indicated by the vertical arrow). *p < 0.05, **p < 0.01 and ^p = 0.07 with respect to values before captopril. Vertical bars represent one SE.

Figure 5.  Mean values (n = 9) of Est,rs before and after 10 and 20 min (A) and of Hy,rs before and after 15 and 30 min (B) captopril administration (time of injection indicated by the vertical arrow). Vertical bars represent one SE. No significant difference was detected.

Figure 5.  Mean values (n = 9) of Est,rs before and after 10 and 20 min (A) and of Hy,rs before and after 15 and 30 min (B) captopril administration (time of injection indicated by the vertical arrow). Vertical bars represent one SE. No significant difference was detected.

As expected from the above reported results, and depicted in , we observed significant reductions in WOBohm,rs mean values at both 10 and 20 min, and in WOBres,rs value at 10 min from i.p. captopril administration (the reduction in WOBres,rs at 20 min resulted almost only significant, p = 0.07). Although a trend indicating a time-related reduction in WOBvisc,rs mean values was observed after captopril (), these changes resulted not significant (see above), as well as the observed changes in WOBel,rs (). The reduction of WOBres,rs resulted, however, high enough to cause a significant decrement in WOBtot,rs mean values both after 10 and 20 min after captopril ().

Table 1.  Mean values of respiratory work of breathing and its components.

A trend indicating a time-related significant reduction of heart rate was observed ().

Table 2.  Heart rate mean values (±SE, n = 9) over time from captopril injection (time = 0).

Discussion

Intraperitoneal administration of presently used captopril dosage is a well documented procedure in rat27–29.

The values of respiratory mechanics parameters here measured and calculated are similar to those previously obtained in analogous experiments performed in different laboratoriesCitation16,Citation22,Citation24,Citation30,Citation31.

Our finding of reduced Rmin,rs as an effect of ACE inhibition () confirms that angiotensin exerts a bronchoconstrictor effect even in basal conditionsCitation3–5, suggesting that it may play a role in the modulation of airway calibre in healthy mammals.

The observed time-related reduction of heart rate (), probably due to a deepening of anaesthesia level in time, suggests a time-related reduction of sympathetic tone also. This would led to an increase of Rmin,rs in time, while an actual decrement was observed, suggesting that the bronchoconstrictor effect of angiotensin has to be considered rather strong.

The decrement of Rmin,rs we observed is agreement with most previously published results (see above), but in contrast with other experiments. However, the authors of the latter used clinically hypotensive low dosages of ACE inhibitors different from captoprilCitation9,Citation10, or tested much lower captopril dosagesCitation11.

By applying the end-inflation occlusion method, we have been able also to measure the overall inflation inspiratory pressure dissipation including the viscoelastic effects due to stress relaxation. It has been shown that ACE inhibition significantly reduces the overall respiratory system resistance to inflation (), hence the overall resistive inspiratory work of breathing (see below).

The analysis of the data describing the ACE inhibition effects on the isolated Rvisc,rs demonstrates a trend to a time-related reduction, which however does not achieve statistical significance (). This is probably due to a lack of statistical power secondary to the dispersion in the individual data. Nevertheless, Rvisc,rs is included in Rmax,rs, which has been here shown to decrease significantly after ACE inhibition, strongly suggesting that angiotensin effects in basal conditions are to increase not only the ohmic airway resistance but also the viscoelastic one, which is measurable as stress relaxationCitation13–16.

In basal conditions, the viscous component of the inspiratory pressure dissipation represented by stress relaxation substantially contributes to the total resistive work of breathing13–16,32, but its molecular mechanism(s) remain largely unclear and poorly understood.

It has been shown that it is increased as an effect of increased lung blood volume and flowCitation31, in inflamed lung tissueCitation24,Citation33,Citation34, and decreased as an effect of body warmingCitation16, but it is not influenced by oestrous cycle in the rat35. Here, a possible effect of basal angiotensin plasma concentration on stress relaxation is hypothesised. In fact, it has previously been shown that smooth muscle cells contraction influencing agents such as nitric oxide may change the activity of the contractile peripheral lung cellular elementsCitation17,Citation18. Influences of these cellular elements activity on the viscoelastic characteristics of the respiratory system can not be excludedCitation32. Angiotensin is known to exert its stimulating activity in a wide population of contractile cells, and captopril has been shown to induce nitric oxide releaseCitation36, so that an effect on stress relaxation may be hypothesized, although more work is needed to verify this working hypothesis.

Although biochemical interactions between angiotensin and alveolar surfactant have been describedCitation19, no data are available describing the effect of angiotensin or ACE inhibition on respiratory system hysteresis and elastance. In the present experiments, no significant effect was found. Hence, ACE inhibition and basal angiotensin plasma concentration do not influence the elastic mechanical properties of the respiratory system in healthy mammals ().

The functional effect of the ACE inhibition-linked reduction of Rmin,rs and Rmax,rs is a significant decrement of the related resistive inspiratory work of breathing (see ). Our data confirm that WOBvisc,rs represents the major part of WOBres,rs13,14,16,24. ACE inhibition significantly reduces both WOBres,rs and WOBohm,rs while the reduction of the isolated WOBvisc,rs does not achieve statistical significance (see above). The changes of WOBres,rs are high enough to cause a significant reduction of the overall inspiratory work of breathing (WOBtot,rs), even in the presence of a not significant reduction of the elastic component (WOBel,rs).

The procedure adopted to calculate the work of breathing and its components introduced an approximation due to the well-known volume-dependence of resistive pressures in the respiratory system, the effects of which were not considered here. However, on the basis of data published previouslyCitation15, this approximation would have only minor effects, also due to the small volume change in the current study. Moreover, these effects would be expected to affect the results obtained before and after ACE inhibition equally and thus would not be predicted to introduce systematic error.

Conclusions

Our results indicate that the renin-angiotensin system affects the basal bronchomotor tone in anaesthetised healthy mammals in basal conditions.

The observed reductions of the resistive pressures dissipations and of the related WOBres,rs and WOBtot,rs values suggest that substantial ACE inhibition may add beneficial effects on respiratory mechanics to the well-known hypotensive effect in patients assuming captopril. This effect, if confirmed, could determine a substantial reduction of the inspiratory effort and of the work of breathing in hypertensive patients assuming captopril. Thus, a reduction of the frequently observed respiratory failure signs in hypertensive patients might ensue.

Declaration of interest

The authors report no declarations of interest.

References

  • Millar EA, Angus RM, Hulks G, Morton JJ, Connell JM, Thomson NC. Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function. Thorax 1994;49:492–495.
  • Millar EA, Nally JE, Thomson NC. Angiotensin II potentiates methacholine-induced bronchoconstriction in human airway both in vitro and in vivo. Eur Respir J 1995;8:1838–1841.
  • Watanabe K, Myou S, Fujimura M, Tachibana H, Kita T, Nakao S. Importance of the angiotensin type 1 receptor in angiotensin II-induced bronchoconstriction and bronchial hyperresponsiveness in the guinea pig. Exp Lung Res 2004;30:207–221.
  • Veerappan A, Reid AC, Estephan R, O’Connor N, Thadani-Mulero M, Salazar-Rodriguez M et al. Mast cell renin and a local renin-angiotensin system in the airway: Role in bronchoconstriction. Proc Natl Acad Sci USA 2008;105:1315–1320.
  • Krop M, Ozünal ZG, Chai W, de Vries R, Fekkes D, Bouhuizen AM et al. Mast cell degranulation mediates bronchoconstriction via serotonin and not via renin release. Eur J Pharmacol 2010;640:185–189.
  • Chalmers GW, Millar EA, Little SA, Shepherd MC, Thomson NC. Effect of infused angiotensin II on the bronchoconstrictor activity of inhaled endothelin-1 in asthma. Chest 1999;115:352–356.
  • Myou S, Fujimura M, Kurashima K, Tachibana H, Watanabe K, Hirose T. Type 1 angiotensin II receptor antagonism reduces antigen-induced airway reactions. Am J Respir Crit Care Med 2000;162:45–49.
  • Gainer JV, Morrow JD, Loveland A, King DJ, Brown NJ. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med 1998;339:1285–1292.
  • Jamison JP, Glover PJ. Effect of angiotensin converting enzyme inhibition on airway conductance during hypocapnic hyperventilation in normal subjects. Pulm Pharmacol 1995;8:49–51.
  • Bauer KG, Brunel P, Nell G, Quinn G, Kaik GA. Benazepril, an angiotensin converting enzyme inhibitor: Drug interaction with salbutamol and bronchial response to histamine in normal subjects. Br J Clin Pharmacol 1997;44:573–575.
  • Greenberg R, Osman GH Jr, O’Keefe EH, Antonaccio MJ. The effects of captopril (SQ 14,225) on bradykinin-induced bronchoconstriction in the anesthetized guinea pig. Eur J Pharmacol 1979;57:287–294.
  • Shore SA, Stimler-Gerard NP, Coats SR, Drazen JM. Substance P-induced bronchoconstriction in the guinea pig. Enhancement by inhibitors of neutral metalloendopeptidase and angiotensin-converting enzyme. Am Rev Respir Dis 1988;137:331–336.
  • Bates JH, Rossi A, Milic-Emili J. Analysis of the behavior of the respiratory system with constant inspiratory flow. J Appl Physiol 1985;58:1840–1848.
  • Bates JH, Baconnier P, Milic-Emili J. A theoretical analysis of interrupter technique for measuring respiratory mechanics. J Appl Physiol 1988;64:2204–2214.
  • D’Angelo E, Calderini E, Torri G, Robatto FM, Bono D, Milic-Emili J. Respiratory mechanics in anesthetized paralyzed humans: Effects of flow, volume, and time. J Appl Physiol 1989; 67:2556–2564.
  • Rubini A. The effect of body warming on respiratory mechanics in rats. Respir Physiol Neurobiol 2011;175:255–260.
  • Potter CF, Dreshaj IA, Haxhiu MA, Stork EK, Chatburn RL, Martin RJ. Effect of exogenous and endogenous nitric oxide on the airway and tissue components of lung resistance in the newborn piglet. Pediatr Res 1997;41:886–891.
  • Martin RJ, Mhanna MJ, Haxhiu MA. The role of endogenous and exogenous nitric oxide on airway function. Semin Perinatol 2002;26:432–438.
  • Valensin G, Delfini M, Gaggelli E. Selective 1H-NMR relaxation investigations of membrane-bound drugs in vitro. 2. Angiotensin II. Biophys Chem 1986;24:25–31.
  • Buzello W, Diefenbach C, Nigrovic V. Muscle relaxants: A clinical update. Acta Anaesthesiol Scand Suppl 1996;109:165–167.
  • Chang HK, Mortola JP. Fluid dynamic factors in tracheal pressure measurement. J Appl Physiol 1981;51:218–225.
  • Reta GS, Riva JA, Piriz H, Medeiros AS, Rocco PR, Zin WA. Effects of halothane on respiratory mechanics and lung histopathology in normal rats. Br J Anaesth 2000;84:372–377.
  • Bates JH, Hunter IW, Sly PD, Okubo S, Filiatrault S, Milic-Emili J. Effect of valve closure time on the determination of respiratory resistance by flow interruption. Med Biol Eng Comput 1987;25:136–140.
  • Rubini A. IL-6 increases airway resistance in the rat. Cytokine 2010;51:266–273.
  • Coussa ML, Guérin C, Eissa NT, Corbeil C, Chassé M, Braidy J et al. Partitioning of work of breathing in mechanically ventilated COPD patients. J Appl Physiol 1993;75:1711–1719.
  • Diamond L, O’Donnell M. Pulmonary mechanics in normal rats. J Appl Physiol 1977;43:942–948.
  • Voigt JP, Bramlage P, Fink H. Hypophagic effect of the angiotensin AT1 receptor antagonist irbesartan in rats. Eur J Pharmacol 2007;564:131–137.
  • Oruc N, Ozutemiz O, Nart D, Yuce G, Celik HA, Ilter T. Inhibition of renin-angiotensin system in experimental acute pancreatitis in rats: A new therapeutic target? Exp Toxicol Pathol 2010;62:353–360.
  • Chen CM, Chou HC, Wang LF, Lang YD. Captopril decreases plasminogen activator inhibitor-1 in rats with ventilator-induced lung injury. Crit Care Med 2008;36:1880–1885.
  • Peratoner A, Nascimento CS, Santana MC, Cadete RA, Negri EM, Gullo A et al. Effects of propofol on respiratory mechanic and lung histology in normal rats. Br J Anaesth 2004;92:737–740.
  • Rubini A, Gasperetti A, Catena V, Del Monte D. Effects of acute blood volume expansion on respiratory mechanics in the rat. Respiration 2010;79:497–505.
  • Faffe DS, Zin WA. Lung parenchymal mechanics in health and disease. Physiol Rev 2009;89:759–775.
  • Xisto DG, Farias LL, Ferreira HC, Picanço MR, Amitrano D, Lapa E Silva JR et al. Lung parenchyma remodeling in a murine model of chronic allergic inflammation. Am J Respir Crit Care Med 2005;171:829–837.
  • Silva PL, Passaro CP, Cagido VR, Bozza M, Dolhnikoff M, Negri EM et al. Impact of lung remodelling on respiratory mechanics in a model of severe allergic inflammation. Respir Physiol Neurobiol 2008;160:239–248.
  • Rubini A, Bondì M. Effect of the oestral cycle on respiratory mechanics in the rat. Acta Physiol (Oxf) 2007;189:379–383.
  • Salvemini D, Pistelli A, Mollace V. Release of nitric oxide from glyceryl trinitrate by captopril but not enalaprilat: In vitro and in vivo studies. Br J Pharmacol 1993;109:430–436.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.